Clinical trial
An Exploratory Trial of Esketamine for the Treatment of Rett Syndrome
NCT06199700 is registered in ClinicalTrials.gov with Children's Hospital of Fudan University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Exploratory Trial of Esketamine for the Treatment of Rett Syndrome
- Lead sponsor
- Children's Hospital of Fudan University
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- November 15, 2023
- Completion date
- December 30, 2025
- Enrollment
- 3 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.